We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Combination of DBT and Standard Mammography Detects Breast Cancer More Often Than Mammography Alone

By HospiMedica International staff writers
Posted on 28 Apr 2022

Breast cancer is the most frequent tumor disease worldwide. More...

This is why, women aged 50 and over are offered systematic early detection examinations - so-called mammography screening. Now, a new study on enhanced screening technology involving almost 100,000 women has found that breast cancer can be detected more often by combining digital breast tomosynthesis (DBT) with synthetic 2D mammography than by standard mammographies.

Researchers at the University of Münster (North Rhine-Westphalia, Germany) have been conducting research in the field of innovative imaging technologies and their impact on the efficiency of detecting breast cancer at an early stage. In the ToSyMa study, a combination of DBT and so-called synthetic 2D mammograms was compared with the nowadays screening standard.

Initial results from study phase 1 confirm the assumption that by using the new enhanced mammography technology, breast cancer is detected significantly more often than by using standard mammography. This observation is based on the fact that breast tomosynthesis – an enhanced version of digital mammography – provides technology which, by computing pseudo-3D datasets, reduces any potential overlapping of tissue in the breast, thus promising benefits in making diagnoses. Phase 2 of the ToSyMa study will examine whether the increase in breast cancer diagnoses as a result of screening also leads to improved health in women.

Related Links:
University of Münster 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.